Loading clinical trials...
Loading clinical trials...
This protocol will evaluate the sensitivity and specificity of \[124I\]FIAU as a diagnostic imaging agent for the detection of prosthetic joint infections in patients.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
BioMed Valley Discoveries, Inc
NCT05361941 · Periprosthetic Joint Infections
NCT05159739 · Total Joint Arthroplasty, Periprosthetic Joint Infections
NCT06440564 · Periprosthetic Joint Infections
NCT06456424 · Prosthetic Joint Infections of Hip, Staphylococcus Aureus Infection
NCT01957228 · Prosthetic Joint Infections
Coastal Clinical Research, Inc.
Mobile, Alabama
Tucson Orthopaedic Institute
Tucson, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions